GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Cash Flow from Others

Aelis Farma (XPAR:AELIS) Cash Flow from Others : €-0.90 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Cash Flow from Others?

Aelis Farma's cash flow from others for the six months ended in Dec. 2023 was €1.30 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.90 Mil.


Aelis Farma Cash Flow from Others Historical Data

The historical data trend for Aelis Farma's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Cash Flow from Others Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial 0.27 0.25 0.35 4.39 -0.90

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 4.78 -0.39 -2.20 1.30

Aelis Farma Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.90 Mil.

Aelis Farma Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines